Prevention of post procedural acute kidney injury in the catheterization laboratory in a real-world population

Chorin, Ehud; Ben–Assa, Eyal; Konigstein, Maayan; Rofe, May-Tal; Hochstadt, Aviram; Galli, Naama; Schnapper, Michael; Arbel, Yaron; Rabey, Ilan; shoshan, Jeremy Ben; Halkin, Amir; Herz, Itzhak; Finkelstein, Ariel; Bazan, Samuel; Keren, Gad; Banai, Shmuel

doi:10.1016/j.ijcard.2016.10.028

Cited by 18 publications

(9 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Visconti et al also categorized CI‐AKI as increase in sCr >0.3 mg/dL or >1.5‐1.9 times above baseline within 7 days post‐procedure. Briguori et al, Chorin et al, and Ben Assa et al defined CI‐AKI as an absolute rise in sCr of 0.5 mg/dL or 25% rise at 48 h, 24‐72 h, and 48‐72 h post‐procedure, respectively . No definition of CI‐AKI was reported in the abstract by Bertelli et al…”

Section: Resultsmentioning

confidence: 99%

Use of the RenalGuard system to prevent contrast‐induced AKI: A meta‐analysis

Mattathil

Prasad

Weinerman

et al. 2017

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Use of the RenalGuard system to prevent contrast‐induced AKI: A meta‐analysis

Mattathil

Prasad

Weinerman

et al. 2017

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

“…Her data revealed that her high plasma UA level was related to renal calculus formation in the transplanted kidney, that the transplanted kidney had been injured, and that the plasma creatinine level was high (10). The use of a contrast agent during the PCI would have increased the risk of kidney injury, the kidney injury, likely to be the contrast agent, was a risk factor in turn for elevated plasma UA and creatinine levels (11). However, this patient did not develop acute kidney injury (AKI) immediately post-PCI (plasma creatinine level, 66 μmol/L immediately post-PCI).…”

Section: Discussionmentioning

confidence: 99%

Acute myocardial infarction after renal transplantation treated with percutaneous coronary intervention: a valuable lesson from a clinical case report

et al. 2021

View full text Add to dashboard Cite

patient who had an AMI post-RT and who had undergone PCI and developed complications with renal calculus formation and upper GI bleeding. We describe this patient's prognosis, complications and follow-up. Also, we discussed management to prevent complications in this clinical case, which is different to previous ones.We present the following article in accordance with the CARE reporting checklist (available at http://dx.doi.

show abstract

“…Consistent with RCTs, several observational studies using real‐world populations have demonstrated the efficacy of this system. In a study by Chorin, 150 patients undergoing coronary angiography, angioplasty, or TAVR who were considered to be at high risk for CIN received forced diuresis with matched hydration and exhibited a significant decrease in their incidence of AKI . In addition, Briguori and colleagues, using the RenalGuard system, demonstrated that a mean intraprocedural urine flow rate of ≥450 mL/h is effective at preventing AKI in high‐risk patients .…”

Section: Discussionmentioning

confidence: 99%

“…[6][7][8][9] Recently, the RenalGuard system has also been shown to be effective in preventing kidney injury in high-risk patients undergoing transcatheter aortic valve replacement In a study by Chorin, 150 patients undergoing coronary angiography, angioplasty, or TAVR who were considered to be at high risk for CIN received forced diuresis with matched hydration and exhibited a significant decrease in their incidence of AKI. 25 In addition, Briguori and colleagues, using the RenalGuard system, demonstrated that a mean intraprocedural urine flow rate of ≥450 mL/h is effective at preventing AKI in high-risk patients. 26 Similarly, Visconti and colleagues showed that the RenalGuard system was effective at preventing AKI in 48 patients with CKD undergoing TAVR.…”

Section: Discussionmentioning

confidence: 99%

High‐volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast‐induced nephropathy: A meta‐analysis of randomized trials

Shah

Wood

Khan

et al. 2017

Clinical Cardiology

View full text Add to dashboard Cite

Background Contrast‐induced nephropathy (CIN) is a well‐recognized complication of coronary angiography that is associated with poor outcomes. Several small randomized controlled trials (RCTs) have recently shown that in patients with chronic kidney disease (CKD), furosemide‐induced forced diuresis with matched hydration using the RenalGuard system can prevent its occurrence. However, individual studies have been underpowered and thus cannot show significant differences in major clinical endpoints. Hypothesis Forced diuresis with matched hydration using the RenalGuard system improves clinical outcomes in patients undergoing coronary angiography. Methods Scientific databases and websites were searched for relevant RCTs. The pooled risk ratios were calculated using random‐effects models. The primary endpoint was CIN, and the secondary endpoints were major adverse clinical events (MACEs) and the need for renal replacement therapy. Results Data from 3 trials including 586 patients were analyzed. High‐volume forced diuresis with matched hydration using the RenalGuard system decreased risk of CIN by 60% (risk ratio: 0.40, 95% confidence interval: 0.25 to 0.65, P < 0.001), MACE rate by 59%, and the need for renal replacement therapy by 78%, compared with the standard of care. Conclusions In patients with CKD undergoing coronary angiography, high‐volume forced diuresis with matched hydration using the RenalGuard system significantly reduces the risk of CIN, MACE rate, and the need for renal replacement therapy. Larger RCTs with sufficient power are needed to confirm these findings.

show abstract

Prevention of post procedural acute kidney injury in the catheterization laboratory in a real-world population

Cited by 18 publications

References 30 publications

Use of the RenalGuard system to prevent contrast‐induced AKI: A meta‐analysis

Use of the RenalGuard system to prevent contrast‐induced AKI: A meta‐analysis

Acute myocardial infarction after renal transplantation treated with percutaneous coronary intervention: a valuable lesson from a clinical case report

High‐volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast‐induced nephropathy: A meta‐analysis of randomized trials

Contact Info

Product

Resources

About